More on PCRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $22.86 |
|
|||
| Open | $22.68 | ||||
| 52 Wk High | $80.25 | ||||
| 52 Wk Low | $30.25 | ||||
| Day High | $22.78 | ||||
| Day Low | $21.49 | ||||
| P/E | N/A | ||||
| EPS | $-2.08 | ||||
| Volume | 603,027 | ||||
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PharmaCorp Announces Grant of Stock Options
- Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference
- Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)
- Pacira Pharmaceuticals (PCRX) PT Lowered to $27 at Truist Securities
- Form S-8 Pacira BioSciences, Inc.
- Form 10-K Pacira BioSciences, Inc. For: Dec 31
- Pacira Pharma (PCRX) Misses Q4 EPS by 33c ; Offers Guidance
- Form 8-K Pacira BioSciences, Inc. For: Feb 26
- Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
Entities mentioned with PCRX
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Stock Buyback | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
